Literature DB >> 15823651

Investigation of a nosocomial outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a hospital setting.

A Carbonne1, T Naas, K Blanckaert, C Couzigou, C Cattoen, J-L Chagnon, P Nordmann, P Astagneau.   

Abstract

A nosocomial outbreak of epidemiologically related VEB-1 extended-spectrum beta-lactamase-producing isolates of Acinetobacter baumannii occurred in 33 patients in an intensive care unit. A case-control study identified previous treatment with third-generation cephalosporins as the only risk factor for A. baumannii acquisition. Rationale for antibiotic use should be strengthened.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15823651     DOI： 10.1016/j.jhin.2004.07.027

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN： 0195-6701            Impact factor:   3.926


  9 in total

1.  Multi-drug-resistant gram-negative bacterial infection in surgical patients hospitalized in the ICU: a cohort study.

Authors:  V G Alexiou; A Michalopoulos; G C Makris; G Peppas; G Samonis; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-28       Impact factor: 3.267

2.  Complex genetic structures with repeated elements, a sul-type class 1 integron, and the blaVEB extended-spectrum beta-lactamase gene.

Authors:  Thierry Naas; Daniel Aubert; Thierry Lambert; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

3.  Spread in an Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended-spectrum beta-lactamase.

Authors:  Andrea Endimiani; Francesco Luzzaro; Roberta Migliavacca; Elisabetta Mantengoli; Andrea M Hujer; Kristine M Hujer; Laura Pagani; Robert A Bonomo; Gian Maria Rossolini; Antonio Toniolo
Journal:  Antimicrob Agents Chemother       Date:  2007-04-02       Impact factor: 5.191

Review 4.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

Review 5.  Treatment options for multidrug-resistant Acinetobacter species.

Authors:  Jacob Gilad; Yehuda Carmeli
Journal:  Drugs       Date:  2008       Impact factor: 9.546

6.  Multi-drug resistant Acinetobacter ventilator-associated pneumonia.

Authors:  Vishal B Shete; Dnyaneshwari P Ghadage; Vrishali A Muley; Arvind V Bhore
Journal:  Lung India       Date:  2010-10

7.  VEB-1 Extended-spectrum beta-lactamase-producing Acinetobacter baumannii, France.

Authors:  Thierry Naas; Bruno Coignard; Anne Carbonne; Karine Blanckaert; Odile Bajolet; Claude Bernet; Xavier Verdeil; Pascal Astagneau; Jean-Claude Desenclos; Patrice Nordmann
Journal:  Emerg Infect Dis       Date:  2006-08       Impact factor: 6.883

8.  Incidence of imipenem-resistant Acinetobacter baumannii in a general intensive care unit (ICU).

Authors:  Mostafa Alavi-Moghadam; Mirmohammad Miri; Majid Mokhtari; Mehran Kouchek; Reza Goharani; Mohammad Sistanzad; Saeed Safari; Mehrdad Solouki
Journal:  Caspian J Intern Med       Date:  2014

Review 9.  Update on the Epidemiology, Treatment, and Outcomes of Carbapenem-resistant Acinetobacter infections.

Authors:  Uh Jin Kim; Hee Kyung Kim; Joon Hwan An; Soo Kyung Cho; Kyung-Hwa Park; Hee-Chang Jang
Journal:  Chonnam Med J       Date:  2014-08-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.